• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,034.57 16.78
( 0.02%)
Global Indices
Nasdaq
49,315.95 353.04
(0.72%)
Dow Jones
7,281.26 59.51
(0.82%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,219.44 -144.49
(-1.39%)
Forex
USD-INR
95.09 0.27
(0.28%)
EUR-INR
111.34 0.19
(0.17%)
GBP-INR
128.90 0.20
(0.16%)
JPY-INR
0.61 0.00
(0.29%)

EQUITY - MARKET SCREENER

Sanofi India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500674
INE058A01010
325.3278333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFI
23.84
7836.76
EPS(TTM)
Face Value()
Div & Yield %
142.76
10
3.61
 

Indoco Remedies reports consolidated net loss of Rs 7.93 crore in the September 2025 quarter
Nov 06,2025
Net Loss of Indoco Remedies reported to Rs 7.93 crore in the quarter ended September 2025 as against net loss of Rs 9.57 crore during the previous quarter ended September 2024. Sales rose 9.56% to Rs 471.83 crore in the quarter ended September 2025 as against Rs 430.66 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales471.83430.66 10
OPM %9.129.35 -
PBDT19.2523.98 -20
PBT-13.00-4.84 -169
NP-7.93-9.57 17